Reimagining cholinergic therapy for Alzheimer’s disease

Giacobini, Ezio, Cuello, A Claudio, Fisher, Abraham·2022·Brain
DOI 10.1093/brain/awac096

Cited by (189)

Items 101–189 of 189

  1. The promising role of bioactive congeners present in Cassytha filiformis in Alzheimer's disease: An explicative review
    Rakhi Khabiya, Dipanjan Karati, Sangeeta Dwivedi, Akanksha Dwivedi, Swarupananda Mukherjee · 2024 · Brain Disorders
  2. Dissociating the involvement of muscarinic and nicotinic cholinergic receptors in object memory destabilization and reconsolidation
    Cassidy E. Wideman, Emily P Minard, Jacqueline M. Zakaria, Jayson Dale R. Capistrano, Gavin A. Scott, Boyer D. Winters · 2022 · Neurobiology of Learning and Memory
  3. Serotonergic Modulators in Alzheimer's Disease: A Hope in the Hopeless Condition
    Najlaa Hamed Almohmadi, Hayder M. Al‐Kuraishy, Ali I. Al‐Gareeb, Ali K. Albuhadily, Morkoss Fakhry, Athanasios T. Alexiou, Marios Papadakis, Gaber El‐Saber Batiha · 2025 · Chemistry & Biodiversity
  4. Photochemistry-driven design of small molecule cholinesterase ligands
    Irena Škorić, Maja Sviben, Milena Mlakić, Tena Čadež, Nikolina Maček Hrvat, Zrinka Kovarik · 2025 · Chemico-Biological Interactions
  5. Mulberroside A: A Multi-Target Neuroprotective Agent in Alzheimer’s Disease via Cholinergic Restoration and PI3K/AKT Pathway Activation
    Jin Li, Jiawen Wang, Yaodong Li, Jingyi Guo, Ziliang Jin, Shourong Qiao, Yunxia Zhang, Guoyin Li, Huazhen Liu, Changjing Wu · 2025 · Biology
  6. Associations between peripheral nerve stimulation and cognitive performance: insights from healthy individuals and various disease pathologies
    Xing Liu, Chenyi Yang, Xinyi Wang, Zixuan Wang, Huihui Liao, Huan Liu, Miao Zhang, Lin Zhang, Haiyun Wang · 2025 · Frontiers in Aging Neuroscience
  7. From heart to brain: cognitive potential of propranolol and diltiazem through cholinergic enhancement via butyrylcholinesterase inhibition
    Celtia Domínguez-Fernández, Amit Kumar, Rajnish Kumar, Taher Darreh‐Shori · 2025 · Frontiers in Pharmacology
  8. Lipid metabolism, neuroinflammation, and oxidative stress in Alzheimer disease: an integrated mechanistic review
    Lijuan Lai, Yanfen Tang, Guojun Song, Yongmei Long, Cuiyu Chen, Chao Chen, Wei Li · 2026 · Acta Neurologica Belgica
  9. Cyclic β-hairpin peptide loaded PLGA nanoparticles: A potential anti-amyloid therapeutic
    Bhushan D. Khairnar, Aishwarya Padhye, Vaibhav Madiwal, Anjali Jha, Sachin Hanumantrao Jadhav, Jyutika M. Rajwade · 2023 · Materials Today Communications
  10. Solvents and detergents compatible with enzyme kinetic studies of cholinesterases
    Dane C. Sands, Andrew Davis, Scott C. Banfield, Ian R. Pottie, Sultan Darvesh · 2023 · Chemico-Biological Interactions
  11. Effects of strategic white matter hyperintensities of cholinergic pathways on basal forebrain volume in patients with amyloid-negative neurocognitive disorders
    Ye Eun Kim, Jae‐Sung Lim, Chong Hyun Suh, Hwon Heo, Jee Hoon Roh, E‐Nae Cheong, Yoojin Lee, Jae Woo Kim, Jae‐Hong Lee · 2024 · Alzheimer s Research & Therapy
  12. Dihuang Yinzi improves scopolamine-induced learning and memory impairment by regulating plasma exosome-derived BDNF
    Wenna Su, Yuzhong Du, Wenting Wang, Qinqing Li, Jun‐Long Zhang, Wenbin He · 2025 · Journal of Ethnopharmacology
  13. Cortical acetylcholine response to deep brain stimulation of the basal forebrain in mice
    Khadijah Shanazz, Kun Xie, Tucker Oliver, Jamal Bogan, Fernando Ĺ. Vale, Jeremy Sword, Sergei A. Kirov, Alvin V. Terry, Philip J. O’Herron, David T. Blake · 2025 · Journal of Neurophysiology
  14. 5-Fluorouracil Impairs Transmission of Acetylcholine in the Hippocampus and Induces Cognitive Impairments in Mice
    Xiwen Huang, Shunqing Peng, Yongquan Lan, Wenjun Chen, Jianlin Wu · 2025 · Journal of Integrative Neuroscience
  15. CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatment
    Abraham Fisher, Allan I. Levey · 2025 · Handbook of clinical neurology
  16. Simultaneous profiling of cholinesterases and NAD(P)H in murine hippocampus via a dual-responsive indicator to investigate cholinergic impairment in Alzheimer's disease
    Bin Jiang, Jiayun Guan, Yilin Lv, Chaojie Yang, Minfeng Yang, Xinyu Shen, Bin Xu, Qi Wang, Yuling Qin, Li Jun Wu · 2025 · Sensors and Actuators B Chemical
  17. Synergistic Neuroprotection in Tauopathic Mice via Green-Synthesized Silver Nanoparticles Co-delivering Methylene Blue and Moringa oleifera
    Yasmin Elbermawy, Sara El-Desouky, Reem K. Arafa, Sara Elfarrash, Ahmad Raafat Bassiouny · 2025 · Molecular Neurobiology
  18. AChE/BuChE inhibitory, DNA nuclease and cytotoxic properties of axially 5-[6-(benzyloxy)-2H-1,3-benzoxazin-3(4H)-yl]pentanoxy and 5-[6-(hexyloxy)-2H-1,3-benzoxazin-3(4H)-yl]pentanoxy substituted silicon phthalocyanines
    Zekeriya Bıyıklıoğlu, Gökçe Seyhan, Berivan Arin Öztürmen, Kübra Kolci, Rengin Reis, Burak Barut · 2023 · Journal of Organometallic Chemistry
  19. Are pharmacotherapeutics effective for treating aphasia?
    Guadalupe Dávila, Marcelo Luis Berthier · 2024 · Expert Review of Neurotherapeutics
  20. Mechanisms of the Pathogenesis of Alzheimer’s Disease: The Role of the Basal Forebrain
    Valentina F. Kitchigina, Irina Yu. Popova, Liubov Shubina · 2025 · Neuroscience and Behavioral Physiology
  21. Memory network and cognitive reserve are associated with preserved and stimulated cholinergic neurotransmission
    Cecilia Boccalini, Daniela Perani, Valentina Garibotto · 2025 · Handbook of clinical neurology
  22. PHARMACOLOGICAL TREATMENT OF ALZHEIMER'S DISEASE: AN INTEGRATIVE REVIEW ON THE EFFECTIVENESS OF CHOLINESTERASE AND MEMANTINE INHIBITORS
    Camilla Fruchtengarten, Laura Maria Vargas Resende e Ribeiro, Marina Magalhães Schichman, Bruno Pyramo Braga de Souza, Daisy Meni Alves de Sousa, Guilherme da Mata Vieira, Deborah Ferreira Duguet Arruda, Laura Figueiró Euler Vaz de Melo Fernandes, Júlia Pereira Santa Bárbara, LAURA MOORE GAISSLER et al. · 2023 · International Journal of Health Science
  23. Cholinergic and behavior‐dependent beta and gamma waves are coupled between olfactory bulb and hippocampus
    Lai-Wo Stan Leung, Ravnoor Singh Gill, Bixia Shen A, Liang-Wei Chu · 2024 · Hippocampus
  24. Development of novel aza-stilbenes as a new class of selective MAO-B inhibitors for the treatment of Parkinson’s disease
    Damijan Knez, Fen Wang, Wen-Xiang Duan, Martina Hrast, Stanislav Gobec, Xiao-Yu Cheng, Xiaobo Wang, Cheng-Jie Mao, Chun‐Feng Liu, Rok Frlan · 2024 · Bioorganic Chemistry
  25. Why do we need new therapies for neurodegenerative disorders?
    Mahmoodullah Azimi, Mohammad Asif Atiq · 2024 · Elsevier eBooks
  26. Rapid and simple sensing of acetylcholinesterase and inhibition activity by utilizing a portable Raman spectrometer
    Jing Tang, Jinyue Feng, Huanhua Liang, Yilan Pang, Zhijiao Tang, Zhengyi Chen, Jian Liang, Yumin Wang · 2025 · Talanta
  27. Emulsion-enhanced synergy of walnut-derived hexapeptide (EPEVLR) and DHA in mitigating D-galactose-induced cognitive decline in mice
    Like Lin, Li Zhang, Cong Li, Lihua Jin, Rui Wang, Yu Shu, Bang Chen, Yehua Shen · 2025 · Food Hydrocolloids for Health
  28. Photobiomodulation Ameliorates Neuronal Damage in an Amyloid-Beta Induced Rat Model
    Na Li, Na Liu, Yutong Ye, Haoxin Shi, Jia Shi, Guoshuai Luo, Jun Guo, Yi Liu, Hongli Chen · 2025 · IEEE Journal of Selected Topics in Quantum Electronics
  29. A brief history of the CNS cholinergic transmission
    A. Claudio Cuello, Ezio Giacobini · 2025 · Handbook of clinical neurology
  30. NGF-based cholinergic therapies in Alzheimer disease
    Sumonto Mitra, Ruchi Gera, Maria Eriksdotter · 2025 · Handbook of clinical neurology
  31. Testing effects of paced breathing on plasma Aβ and brain perivascular spaces
    Kaoru Nashiro, Jungwon Min, Hyun Joo Yoo, Christine Cho, Martin J. Dahl, Paul Choi, Hye Rynn J. Lee, Jeiran Choupan, Noah Mercer, Padideh Nasseri et al. · 2026 · International Journal of Psychophysiology
  32. N- Salicyloyl Tryptamine Derivatives Improve Mitochondrial Function To Treat Alzheimer’s Disease
    Jing Zeng, Yuting Zhao, Yaxin Chen, Kun Wu, Changlei Yang, Yinyin Wu, Guanglong Pang, Miao Zhang, Huaixiu Wen, Zhen Wang et al. · 2026 · ACS Omega
  33. Network pharmacology-guided identification and molecular validation of multi-target phytoconstituents from Gmelina arborea against Alzheimer’s disease
    Amit Gangwal, Iqrar ANSARİ, Jyotiram Arjun Sawale, Azim Ansari · 2026 · In Silico Research in Biomedicine
  34. Nerve growth factor responsive elements modulate immune cell inflammation and are dysregulated in an Alzheimer’s disease mouse model
    Ruchi Gera, Giuseppe Mocci, Simone Tambaro, Michael Vanlandewijck, Per Nilsson, Maria Eriksdotter, Sumonto Mitra · 2026 · Frontiers in Immunology
  35. Leveraging multitargeting BChE-MAO B inhibitors against microglia-related neuroinflammation: in vitro biological evaluation, structure-activity relationships, drug-like properties, and X-ray crystal complexes.
    Mariagrazia Rullo, Gabriella La Spada, X. Brazzolotto, Sara Marchese, Imane G. El Idrissi, Morena Miciaccia, Marco Colella, J. Bréa, Eleonora Macchia, M. I. Loza et al. · 2026 · European journal of medicinal chemistry
  36. α-Synuclein as a molecular link between Parkinson’s disease and chronic kidney disease: insights into the kidney-brain axis
    Shavinder Kumari, Nishant Goutam, Vaishali Chaudhary, Shakshi Rana, Shiv Kumar Kushawaha, Alka Sharma, Mahendra Singh Ashawat, Gaurav Joshi, Neeraj Joshi · 2026 · Metabolic Brain Disease
  37. Innovative Test Strip‐Based Colorimetric Sensors Integrated With Affinity Chromatography: Acetylcholinesterase Inhibitor Screening Breakthrough in Lycium Barbarum Leaves
    Yuping Sa, Hui Yuan, Jingui Ma, Zhigang Yang, Mei Wang, Weibiao Wang, Lingling Yang, Fen Ma, Weiman Zhang, Gidion Wilson et al. · 2026 · Advanced Science
  38. Interactions with amyloid beta peptide and acetylcholinesterase increase alkaline phosphatase activity
    Ashlesha Bhide, Ayusman Sen · 2023 · Physical Chemistry Chemical Physics
  39. Pharmacophore-based virtual screening of the chromone derivatives as potential therapeutic for Alzheimer’s disease
    Naveen Kumar, Bharti Devi, Kailash Jangid, Vinod Kumar · 2025 · Journal of Biomolecular Structure and Dynamics
  40. New Peripheral Pyridine‐Substituted Cobalt, Copper, and Manganese Phthalocyanines as Potential In Vitro Acetyl/Butyrylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease
    Halise Yalazan, Gökçe Seyhan, Şeyma Özkan, Burak Barut, Zekeriya Bıyıklıoğlu, Halıt Kantekın · 2025 · Applied Organometallic Chemistry
  41. Long-term nucleus basalis cholinergic lesions alter the structure of cortical vasculature, astrocytic density and microglial activity in Wistar rats
    Chiara Orciani, Morgan K. Foret, A. Claudio Cuello, Sonia Do Carmo · 2025 · Neurobiology of Aging
  42. Cholinergic therapy in Alzheimer disease
    Serge G. Gauthier, Joseph Therriault, Pedro Rosa‐Neto · 2025 · Handbook of clinical neurology
  43. Pharmacokinetic and Pharmacodynamic Evaluation of PZ-2891, an Anti-Alzheimer’s Disease Agonist of PANK2
    Ying Chen, Huimin Ma, Mengyao Jin, Shize Zhang, Shimeng Qu, Guangji Wang, Jiye Aa · 2025 · Pharmaceuticals
  44. Network Pharmacology-guided Identification and Molecular Validation of Multi-Target Phytoconstituents from Gmelina arborea against Alzheimer’s Disease
    Amit Gangwal, Azim Ansari, Iqrar Ansari, Jyotiram Arjun Sawale, Ling Shing Wong, Vetriselvan Subramaniyan, Vinoth Kumarasamy · 2025 · Research Square
  45. Exploring potential inhibitors from Eriobotrya japonica targeting AChE and BChE in Alzheimer's Disease through docking, ADMET profiling, and DFT analysis
    Mubashir Afzal, Aleena Sajjad, Muhammad Bilal Iqbal Rehmani, Sameer Nasir, Sheikh Muhammad Yahya Waseem, Muhammad Asif Akram, Iqra Irshad, Shagufta Bashir, Mehdi Rahimi · 2025 · Research Square
  46. Serious doubts about amyloid-β (Aβ) biomarkers and anti-Aβ immunotherapy
    Poul Flemming Høilund‐Carlsen, Abass Alavi, Tommaso Costa, Rachael L. Neve, Mona-Elisabeth R. Revheim, Jorge R. Barrio · 2026 · Journal of Alzheimer s Disease
  47. Analysis of the mitochondrial status of murine neuronal N2a cells treated with resveratrol and synthetic isomeric resveratrol analogs: aza-stilbenes
    Mohamed Ksila, Imen Ghzaiel, Aline Yammine, Thomas Nury, Anne Véjux, Dominique Fasseur, Norbert Latruffe, Emmanuelle Prost-Camus, Smail Meziane, Olfa Masmoudi‐Kouki et al. · 2022 · Elsevier eBooks
  48. Impairment of exocytotic transmitter release by decynium-22 through an inhibition of ion channels
    Gabriele Haar, Katsiaryna Hrachova, Tanja Wagner, Stefan Boehm, Klaus W. Schicker · 2023 · Frontiers in Pharmacology
  49. Carltonine-Derived Compounds for Targeted Butyrylcholinesterase Inhibition
    Filip Pidaný, Jana Křoustková, Jaroslav Jenčo, Katerina Hradiska Breiterova, Ľubica Múčková, Lucie Nováková, Jiřı́ Kuneš, Jakub Fibigar, Tomas Kucera, Ales Sorf et al. · 2023 · SSRN Electronic Journal
  50. Recent advances in cholinergic mechanisms: A preface for the ISCM2022 special issue
    Zrinka Kovarik, Hermona Soreq · 2023 · Journal of Neurochemistry
  51. Literature cited
    2024 · Elsevier eBooks
  52. AMMONIUM AMPHIPHILES BASED ON NATURAL COMPOUNDS: DESIGN, SYNTHESIS, PROPERTIES AND BIOMEDICAL APPLICATIONS. A REVIEW
    Tatiana N. Pashirova, Zukhra M. Shaihutdinova, Vladimir Fedorovich Mironov, Andrei V. Bogdanov · 2023 · Доклады Российской академии наук Химия науки о материалах
  53. Exploring the potential mechanism of Polygonatum sibiricum for Alzheimer's disease based on network pharmacology and molecular docking
    Liangliang Luo, Yao Pan, Fang Chen, Zhihong Zhang · 2024 · Research Square
  54. Interaction between mitochondrial translocator protein and aging in inflammatory responses in mouse hippocampus
    Kei Onn Lai, Nevin Tham, Lauren Hermes Fairley, Roshan Ratnakar Naik, Yulan Wang, Sarah R. Langley, Anna M. Barron · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Demencias. ¿Qué hacemos hoy y qué podríamos hacer? Análisis de una cohorte en el mundo real de pacientes con trastornos cognitivos y conductuales
    Daniel Raúl Zuin, Francisco Peñalver, María Paula Zuin · 2024 · Neurología Argentina
  56. Dementia. Specifics of its manifestations. Clinical patterns of dementia in Alzheimer's disease
    Р. К. Ширалиева · 2024 · Cifra. Клиническая медицина.
  57. The role of the basal forebrain in the pathogenesis of Alzheimer’s disease
    Valentina F. Kitchigina, Irina Yu. Popova, Liubov Shubina · 2024 · Журнал высшей нервной деятельности им И П Павлова
  58. In Vitro Investigation of Acetylcholinesterase Inhibition by Methanolic Extract of Muntingia calabura Bark
    S P Venkanna, A Lidia, Apurva Kumar Ramesh Joshi · 2025 · Current Enzyme Inhibition
  59. Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
    Ying Xia, Pierrick Bourgeat, Vincent Doré, Jürgen Fripp, Yen Ying Lim, Simon Matthew Laws, Christopher James Fowler, Christopher C. Rowe, Colin Louis Masters, Elizabeth Jane Coulson et al. · 2025 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  60. Novel diazepine-carbamate derivatives as dual-acting butyrylcholinesterase inhibitors and antioxidants for Alzheimer’s disease
    Nafisah Al‐Rifai, Rayanah Amro, Jalal A. Zahra, Fouad H. Darras, Mutasem O. Taha · 2025 · Medicinal Chemistry Research
  61. The Role of Nutraceuticals in the Treatment of Neurodegenerative Diseases
    Leena Kumari, Aparna Datta, Poulami Sen, Soumen Dhara, Hemant Ramachandra Badwaik · 2025 · BENTHAM SCIENCE PUBLISHERS eBooks
  62. Network Pharmacology-guided Identification and Molecular Validation of Multi-Target Phytoconstituents from Gmelina arborea against Alzheimer’s Disease
    Amit Gangwal, Azim Ansari, Iqrar ANSARİ, Jyotiram Arjun Sawale · 2026 · Research Square
  63. Functional Evaluation of Tetrahydroisoquinoline-Derived Ligands Reveals Distinct Modulatory Profiles at the Muscarinic M1 Receptor
    Juan Pablo González-Gutiérrez, Damián Castillo-Ríos, Ignacio Alejandro González-Gutiérrez, Dante R. Palma-Ruíz, Isabel Vidal-Beltrán, Ingrid Carvacho, Fernando Hinostroza · 2026 · ACS Medicinal Chemistry Letters
  64. Botany, phytochemistry, pharmacology, phytotoxicity and industrial applications of Grewia tiliifolia Vahl: a comprehensive review
    Sarvat Rahim, Laiba Tariq, Amin Shah, Patricio R. De los Rios-Escalante, Ali Khan Mohd. Mubashir, Muhammad Kabir, Gulfam Shahzad, Nuzhat Rasul, Eliana Ibáñez-Arancibia · 2026 · Genetic Resources and Crop Evolution
  65. Carltonine B derivatives: Synthesis and structure-activity relationship insights for selective butyrylcholinesterase inhibition
    Abdullah Al Mamun, Jan Konecny, Martina Hrabinová, Ales Sorf, Ľubica Múčková, Jakub Fibigar, Tomas Kucera, Lenka Pulkrabkova, Daniel Jun, Lukáš Prchal et al. · 2026 · Bioorganic Chemistry
  66. Aging alters the vulnerability pattern to amyloid-beta oligomers in wild-type mice: a behavioral and neurobiological study
    Ahmad Allouche, Julie Colin, Catherine Birck, Henri Schroeder, V. Tallandier, Marion Baldoni, Christophe Muller, Mohamed Afrassi, Nicolas Violle · 2026 · Alzheimer s Research & Therapy
  67. Management of Alzheimer’s Disease-Associated Cognitive Disabilities
    Shiuli Bera, Moumita Kundu · 2026 · SpringerBriefs in modern perspectives on disability research.
  68. Network Pharmacology Reveals the Therapeutic Potential of BBB-Permeable Compounds from Lonicera caerulea for Alzheimer’s Disease and Lipid Metabolism Disorders
    Jiayi He, Jihong Li, Junwei Huo, Yijun Pang, Kaiqi Sun, Haoyu Zhu, Yuhan He, Zhixuan Ren, Xin Cheng, Shuang Ao et al. · 2026 · International Journal of Molecular Sciences
  69. Akkermansia muciniphila and Alzheimer’s Disease: Mechanisms, Evidence and Translational Potential
    J Li, Qiushuang Long, Binglin Zhu · 2026 · Biomolecules
  70. An integrated in silico approach to identify pyridine-based AChE and BChE inhibitors for Alzheimer's disease
    Shivank Sharma, V. V. Ravi Kumar, Stalin Arulsamy, Shubham Kumar, Pankaj K. Wadhwa · 2026 · Computers in Biology and Medicine
  71. Environmental Factors Drive Neurodegenerative Diseases Through Glutamate Excitotoxicity: A Convergent Mechanistic Pathway
    Yulu He, Tingting Yi, Meixin Min, Ke Xu, Huan Lin, Rong Xu, Dan Deng, Xiaoping Xiao · 2026 · Neuroscience Bulletin
  72. Engineering a nanocluster-immobilized MOF@MOF architecture-based ratiometric fluorescence bioassay for sensing neurodegenerative disease-related acetylcholinesterase and inhibitor drugs
    Chao Liu, Jiadi Li, Fengyun Wang, Mengke Wang · 2026 · Analytical Methods
  73. “Behavioral and Neuroinflammatory Evaluation of a Novel Isoxazole-5-One Derivative in Animal Models of Alzheimer’s Disease via TNF-α, COX-2, IL-6, and NF-κB Modulation”
    Nitasha Gohar, Muzaffar Abbas, Syed Muzzammil Masaud, Iqra Zulfiqar, Hafsa Jabeen, Nadia Shamshad Malik, Humaira Nadeem · 2026 · ACS Omega
  74. Tau Protein in Alzheimer's Disease
    Maitreyee Mukherjee, Soumen Dhara, Abhishek Jana, Tathagata Roy · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  75. Non-pharmacological strategies for the management of Alzheimer's disease
    Gunaro Lucas dos Santos de Oliveira, Amanda Gollo Bertollo · 2026 · Dementia & Neuropsychologia
  76. Concurrent Use of Anticholinergic and Antidementia Medicines in Older Adults with Dementia: A Systematic Review of Prevalence, Predictors and Clinical Outcomes
    Zahraa Falfaly, Gregory Mark Peterson, Woldesellassie M Mequanint Bezabhe, Mohammed Saji Salahudeen · 2026 · Medical Sciences
  77. Early functional disconnection of the basal forebrain–hippocampal system predicts memory impairment in amnestic mild cognitive impairment
    Juan‐Juan Lu, Zhi-Jie Xu, Jie Ma, Jia‐Jia Wu, Xin Xue, Xu‐Yun Hua, Jian‐Guang Xu · 2026 · Neuroscience
  78. Computational discovery and dynamic profiling of dual acetylcholinesterase and monoacylglycerol lipase inhibitors for Alzheimer’s disease
    The‐Huan Tran, Thai‐Son Tran, Thanh‐Dao Tran · 2026 · Molecular Diversity
  79. Adult-onset hippocampal α7 nicotinic acetylcholine receptor loss rapidly drives Alzheimer-like neuropathology in mice
    Jun Li, Guang-Lin Liu, Xiao-Tong Wang, Zheng Song, Huan Chen, Hong-Wei Hou, Qing-Yuan Hu · 2026 · Frontiers in Pharmacology
  80. Advances in Targeting Central Cholinergic Dysfunction for Neurodegenerative Diseases: From Pharmacotherapy to Neuromodulation
    Lei Lei, Xiaoyu Hu, Ruida Lu, Jianjun Yang, Qingsheng Meng · 2026 · CNS Neuroscience & Therapeutics
  81. Imidazopyridine–coumarin derivatives as novel multi-target directed ligands (MTDLs): Balancing acetylcholinesterase inhibition and antioxidant activity for neuroprotection
    Pooja, Ankita Kumari, Jeevika Bhat, Poonam, Pratibha Pandey, Laishram Saya, Ramendra Pratap · 2026 · Journal of Molecular Structure
  82. Therapeutic potential of proline-rich peptide-1 (PRP-1) in counteracting amyloid-β-mediated cortical and hippocampal neurodegeneration in a rat model
    Harutyun Stepanyan, Hamzeh Ghorbani, М. V. Poghosyan, Margarita Danielyan, Arsen Minasyan, Arsen S. Hunanyan, Naira Hunanyan · 2026 · Neuroscience
  83. Harnessing Nanozyme Catalytic Activities for Multi-Target Intervention in Neurodegenerative Pathology
    Yanan Wang, Jintao Cheng, Tao Liu, Shiyu Li, Qingchi Wang, Kan Shao, Guiling Yang, Peng Li · 2026 · Nanomaterials
  84. Ishige foliacea Water Extract (KDC22-01) Attenuates Tau Hyperphosphorylation and Ameliorates Scopolamine-Induced Memory Impairment in Mice
    Jung Ho Choi, Won Jin Baek, Suhyun Kim, Myoung‐Sook Shin · 2026 · Nutrients
  85. BindingDB Entry 50021534: Carltonine-derived compounds for targeted butyrylcholinesterase inhibition.
    BindingDB · 2025 · UC San Diego
  86. Down Syndrome Early Postnatal Brain Multiome (DS-HPBM)
    Anita Bhattacharyya, Pubudu Kumarage, Nicole R. West, Kalpana Hanthanan Arachchilage, Sara Knaack, Shawn MacGregor, Masoumeh Hosseini, Ryan D. Risgaard, Jose Martinez, Su‐Chun Zhang et al. · 2022 · INCLUDE Data Hub
  87. DS-HPBM Human Postnatal Basal Forebrain snRNA-seq
    Anita Bhattacharyya, Pubudu Kumarage, Nicole R. West, Kalpana Hanthanan Arachchilage, Sara Knaack, Shawn MacGregor, Masoumeh Hosseini, Ryan D. Risgaard, Jose Martinez, Su‐Chun Zhang et al. · 2022 · INCLUDE Data Hub
  88. DS-HPBM Human Postnatal Basal Forebrain snATAC-seq
    Anita Bhattacharyya, Pubudu Kumarage, Nicole R. West, Kalpana Hanthanan Arachchilage, Sara Knaack, Shawn MacGregor, Masoumeh Hosseini, Ryan D. Risgaard, Jose Martinez, Su‐Chun Zhang et al. · 2022 · INCLUDE Data Hub
  89. Developing precision nanoparticle-based drug delivery systems for Alzheimer's disease therapy
    Qiujie Shan, Wenao Zheng, Weina Yao, Yamei Bai, Wanchuan Ding, Ji Wang, Feng Bai · 2026 · Materials Today Bio